Patient Re-education vs. Background Morphine to IV-PCA in Patient With Unsatisfactory Analgesia Post Laparotomy
Launched by CLINICAL RESEARCH CENTRE, MALAYSIA · Aug 13, 2015
Trial Information
Current as of June 20, 2025
Unknown status
Keywords
ClinConnect Summary
In this study, investigators have a second inclusion criteria for subject recruitment. For subjects who meet this criteria meaning their dynamic pain (when blowing incentive spirometer) is ≥ 4/10 after starting on IV-PCA Morphine will be randomized in to 2 groups. One group will receive patient re--education with an additional background morphine infusion and the other group will receive re--education only.
The second highlight for this study is regarding the background morphine calculation. The background morphine is calculated according to this formula:
Total morphine requirement in the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists (ASA)Physical Status Classification Class I and II
- • Elective laparotomy
- • able to understand either malaysia, mandarin, english language or local dialect
- • patient with dynamic pain score 4/10 and more within the first 4-hour after initiation of IV-PCA
- Exclusion Criteria:
- • patient refusal
- • laparotomy with pfannenstiel incision
- • patients with a history of allergy to opioids
- • patients who required post-operative ventilation support
- • patients ASA III and above
- • patients unable to use PCA due to insufficient comprehension
- • morbid obesity/ obstructive sleep apnea
- • chronic opioid or alcohol abuse
About Clinical Research Centre, Malaysia
Clinical Research Centre Malaysia is a leading institution dedicated to advancing medical science through innovative clinical trials and research initiatives. Based in Malaysia, the Centre focuses on a wide array of therapeutic areas, collaborating with healthcare professionals and industry partners to facilitate rigorous, ethically conducted studies. With a commitment to enhancing patient care and health outcomes, the Centre employs state-of-the-art methodologies and adheres to international standards, ensuring the integrity and reliability of its research findings. By fostering a collaborative research environment, the Clinical Research Centre Malaysia plays a pivotal role in contributing to global medical advancements and improving healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alor Seatr, Kedah, Malaysia
Patients applied
Trial Officials
lee choo yeoh, master
Principal Investigator
CRC Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials